A detailed history of Winning Points Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Winning Points Advisors, LLC holds 7,100 shares of ABT stock, worth $805,140. This represents 0.79% of its overall portfolio holdings.

Number of Shares
7,100
Previous 7,100 -0.0%
Holding current value
$805,140
Previous $780,000 7.82%
% of portfolio
0.79%
Previous 0.99%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $2,376 - $2,788
-25 Reduced 0.35%
7,100 $780,000
Q1 2022

Apr 27, 2022

SELL
$114.02 - $139.04 $91,216 - $111,232
-800 Reduced 10.09%
7,125 $843,000
Q4 2021

Feb 16, 2022

BUY
$115.53 - $141.46 $132,859 - $162,679
1,150 Added 16.97%
7,925 $666,000
Q3 2021

Nov 17, 2021

BUY
$116.66 - $129.06 $46,664 - $51,624
400 Added 6.27%
6,775 $800,000
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $84,632 - $99,624
-800 Reduced 11.15%
6,375 $739,000
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $27,210 - $32,057
250 Added 3.61%
7,175 $860,000
Q4 2020

Feb 01, 2021

SELL
$105.0 - $114.42 $105,000 - $114,420
-1,000 Reduced 12.62%
6,925 $758,000
Q1 2019

Nov 14, 2019

SELL
$66.22 - $80.06 $13,244 - $16,012
-200 Reduced 2.46%
7,925 $634,000
Q4 2018

Nov 12, 2019

BUY
$65.56 - $74.27 $13,112 - $14,854
200 Added 2.52%
8,125 $565,000
Q3 2018

Feb 02, 2021

SELL
$60.81 - $73.36 $12,162 - $14,672
-200 Reduced 2.46%
7,925 $581,000
Q2 2018

Nov 12, 2019

SELL
$57.57 - $63.54 $5,757 - $6,354
-100 Reduced 1.22%
8,125 $496,000
Q1 2018

Nov 12, 2019

SELL
$56.27 - $63.62 $5,401 - $6,107
-96 Reduced 1.15%
8,225 $496,000
Q3 2017

Nov 12, 2019

BUY
$48.06 - $53.64 $19,224 - $21,456
400 Added 5.05%
8,321 $444,000
Q2 2017

Nov 08, 2019

SELL
N/A
-400 Reduced 4.81%
7,921 $386,000
Q1 2017

Nov 08, 2019

BUY
N/A
52 Added 0.63%
8,321 $370,000
Q4 2016

Nov 07, 2019

BUY
N/A
8,269
8,269 $318,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Winning Points Advisors, LLC Portfolio

Follow Winning Points Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winning Points Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winning Points Advisors, LLC with notifications on news.